We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

AnaSpec Introduces new Z-Fish™ Anti-Caspase Antibodies

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
Zebrafish (Danio rerio) is becoming a widely used experimental model for the study of vertebrate development and embryology, toxicology and genomics.

In regards to the field of apoptosis, the zebrafish genome has been found to encode a majority of the components that mediate apoptosis in mammals including humans. Furthermore, apoptosis-regulating genes, such as the Caspases (cysteine aspartic acid proteases), have been cloned from zebrafish.

AnaSpec is providing research tools to keep pace with the growing needs of researchers using zebrafish as an experimental model.

AnaSpec’s Z-Fish™ anti-caspase list includes antibodies for Caspase 2, with immunizing peptides derived from the N-terminus (NT) or an internal sequence (IN); Caspase 3a, 3b antibodies targeting specifically the p12 or p17 domains; Caspase 8a, with the immunizing peptide derived from an internal caspase 8a sequence; Caspase 9 for p10 and p37 domains; and Caspase-a (caspy) and Caspase-b (caspy-2).

These polyclonal antibodies, raised in rabbits, have been verified in ELISA and western blots using zebrafish lysates. Antibodies are supplied in 150 ul sizes and are enough for 15 mini gels.

The list of Z-Fish™ antibodies includes targets used in apoptosis and autophagy, cell cycle control, cytoskeleton, glucose and energy metabolism, signal transduction, and immunity research.